EUCTR2013-000577-77-ES进行中（未招募）1 期
EARLY ORAL SWITCH THERAPY IN LOW-RISK STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONACRONYM: SABATO (Staphylococcus aureus Bacteremia Antibiotic Treatment Options) - SABATO
niversity of Cologne0 个研究点目标入组 213 人开始时间: 2014年8月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 213
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Blood culture positive for S. aureus not considered to represent contamination
- •- 5-7 days of adequate intravenous antimicrobial therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 140
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 290
排除标准
- •- Polymicrobial bloodstream infection
- •- Signs and symptoms of complicated SAB (deep-seated infection, hematogenous dissemination, septic shock, prolonged bacteremia)
- •- Presence of a non-removable foreign body
- •- Severe comorbidity
研究者
相似试验
进行中（未招募）
1 期
Early oral antibiotics in Staphylocopccus aureus bloodstream infectioEUCTR2013-000577-77-DEniversity of Düsseldorf430
进行中（未招募）
不适用
Early oral antibiotics in Staphylocopccus aureus bloodstream infectioow risk Staphylococcus aureus bloodstream infectionMedDRA version: 18.0Level: LLTClassification code 10041943Term: Staphylococcus aureus septicaemiaSystem Organ Class: 100000004862MedDRA version: 18.0Level: LLTClassification code 10054638Term: Staphylococcus aureus septicemiaSystem Organ Class: 100000004862EUCTR2013-000577-77-NLniversity of Cologne430
已完成
3 期
EARLY ORAL SWITCH THERAPY IN LOW-RISK STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIOA41.0Sepsis due to Staphylococcus aureusDRKS00004741niversitätsklinikum Düsseldorf i.A. der Heinrich-Heine-Universität215
已完成
3 期
EARLY ORAL SWITCH THERAPY IN LOW-RISK STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIOresistant bacteria10004018bacterial infectionNL-OMON44940niversity of Düsseldorf60
尚未招募
不适用
Early or Late Intervention in high risk non ST elevation Acute Coronary Syndromes.high risk non-ST elevation acute coronary syndrome patientsNL-OMON26567Diagram B.V.v. Nahuysplein 68011 NB ZwolleThe Netherlands540